TETON Convertible Securities A holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
TETON Convertible Securities Fund Class A WEIAX
- NAV / 1-Day Return 16.42 / −1.38 %
- Total Assets 13.1M
-
Adj. Expense Ratio
1.160%
- Expense Ratio 1.160%
- Distribution Fee Level Average
- Share Class Type Front Load
- Category Convertibles
- Investment Style Small Growth
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 1.21%
- Turnover 63%
USD | NAV as of Jul 14, 2026 | 1-Day Return as of Jul 14, 2026, 12:51 AM GMT+0
Morningstar’s Analysis WEIAX
Will WEIAX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 27.3
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
PPL Capital Funding Inc. 2.875% | 4.15 | 469,100 | Corporate |
Bridgebio Pharma Inc 1.75% | 3.01 | 339,650 | Corporate |
Hewlett Packard Enterprise Co 7.625% PRF CONVERT 01/09/2027 USD 50 - Ser C | 2.86 | 322,550 | Technology |
Digital Realty Trust, L.P. 1.875% | 2.82 | 318,339 | Corporate |
Microchip Technology Inc 7.50% PRF CONVERT 15/03/2028 USD 50 - Ser A 1/20th | 2.52 | 284,850 | Technology |
BrightSpring Health Services Inc Units | 2.52 | 284,080 | Healthcare |
Alibaba Group Holding Ltd. 0.5% | 2.46 | 277,750 | Corporate |
Lumentum Holdings Inc. 0.375% | 2.39 | 269,817 | Corporate |
Applied Digital Corp 2.75% | 2.35 | 265,700 | Corporate |
Cytokinetics Inc 1.75% | 2.26 | 255,375 | Corporate |